Recombinant Modified Vaccinia Virus Ankara Provides Durable Protection Against Disease Caused by an Immunodeficiency Virus as well as Long Term Immunity to an Orthopoxvirus in a Non-Human Primate

Recombinant and non-recombinant modified vaccinia virus Ankara (MVA) strains are currently in clinical trials as human immunodeficiency virus-1 (HIV) and attenuated smallpox vaccines, respectively. Here we tested the ability of a recombinant MVA delivered by alternative needle-free routes (intramusc...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Earl, Patricia L., Americo, Jeffrey L., Wyatt, Linda S., Eller, Leigh Anne, Montefiori, David C., Byrum, Russ, Piatak, Michael, Lifson, Jeffrey D., Amara, Rama Rao, Robinson, Harriet L., Huggins, John W., Moss, Bernard
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2007
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2077303/
https://ncbi.nlm.nih.gov/pubmed/17499326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2007.02.041
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन